India's SeQuent Scientific hits more than 2-1/2-yr high on prequalification nod for drug

Viyash Scientific

20/08/2024 05:09

** Shares of SeQuent Scientific  SEQU.NS  rise as much as
11.1% to 175 rupees, highest since Jan 21, 2022
    ** Stock eyes fourth straight session of gains
    ** The pharma co said on Monday it got pre-qualification
approval from World Health Organization (WHO) for Albendazole,
API
    ** Albendazole medication is used to treat parasitic
infections including tapeworm and roundworm
    ** More than 4.3 mln shares change hands, 2x its 30-day avg
    ** Stock up 39% so far this year; eyes best yearly gain
since 2020


 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))